News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
MIRA Pharmaceuticals announces positive preclinical data for Mira-55, a non-opioid therapy showing morphine-comparable pain relief without local inflammation. The DEA confirms non-controlled status -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Eagle Plains and Xcite Amend Uranium City Option Agreements
Eagle Plains and Xcite Resources amending agreements for Athabasca uranium property portfolio. Projects in partnership with Athabasca First Nations for mineral exploration. Eagle Plains’ focus on Western Canada critical metals exploration